Last checked at 31 Jan 2012 10:44
For Immediate Release | 31 January 2012 |
Genus plc
Notification of Interim Results
for the six months ended 31 December 2011
Genus, a leading global animal genetics company, will announce its interim results for the six months ended 31 December 2011 on Tuesday 21 February 2012.
A briefing for analysts will be held at 10.15am on 21 February 2012 at Buchanan, 107 Cheapside, London EC2V 6DN.
An audio webcast of the presentation will be available following the meeting on Tuesday 21 February 2012. To access the webcast please visit:
http://mediaserve.buchanan.uk.com/2012/genus210212/registration.asp
For further information please contact:
Buchanan Tel: 020 7466 5000
Charles Ryland
Suzanne Brocks
Catherine Breen
About Genus
Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors.
Genus' worldwide sales are made in seventy countries under the trademarks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality, and use these to supply the global dairy and meat supply chain.
The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production and distribution network.
With headquarters in Basingstoke, England, Genus companies operate in thirty countries on six continents, with research laboratories located in Madison, Wisconsin, USA.